Research resources
A curated set of external resources for deeper research into longevity peptide biology — primary-literature databases, key research programmes, UK regulatory references, and research-grade peptide suppliers.
The resources page is intended to be the first stop for any reader who wants to verify a claim made elsewhere on this site or to dig deeper into a specific research thread. The selection criterion is straightforward — we link to sources we use ourselves and have found accurate or authoritative within their scope. Sources that are widely cited but in our judgement editorially unreliable (commercial blog posts framed as scientific reference, undated forum aggregations, broker-style content) are not included regardless of search-result visibility.
The primary-literature section is the most important. PubMed remains the canonical starting point for any peptide-research question; the journal-specific links provide entry points to the publications most frequently cited on this site. The research-institute section identifies the major laboratories whose output dominates each field — the Khavinson group at St Petersburg for short-peptide and cytomedine work, the Cohen laboratory at USC for mitochondrially-derived peptide biology, the Pickart programme for GHK-Cu and copper-peptide work, the Szeto-Schiller and Stealth BioTherapeutics output for SS-31. Reading source from these groups directly is usually more efficient than reading aggregated review articles, particularly where review articles have flattened useful methodological detail.
The regulatory section is included because UK research-peptide framing differs from US framing in important ways, and the published MHRA materials are the authoritative source on this question. The Human Medicines Regulations 2012 is the underlying statute that governs supply and advertising of unlicensed medicinal products in the UK; the ICO is the data-protection regulator for any research handling personal data. Both are linked directly to their canonical resource pages rather than to secondary commentary.
The supplier section identifies UK research-grade material suppliers active in the peptide market. We link to PeptideAuthority.co.uk and PeptideBarn.co.uk because their catalogues and analytical certificates are publicly available and their material is shipped under appropriate research-only labelling. We do not have a commercial relationship with either supplier that influences inclusion, and we do not vouch for the analytical quality of any specific batch — verification of certificates and handling protocols at the point of purchase remains the researcher's responsibility.
Primary literature
The starting point for primary literature on any peptide on this site. We cite PubMed records directly where they exist.
Open-access ageing-biology journal. Multiple papers on Humanin, MOTS-c and SS-31 originate here.
Site of the foundational MOTS-c and Humanin metabolism papers (Lee et al. 2015, Kim et al. 2018).
Research institutes & programmes
Khavinson research programme — origin of Epitalon, Pinealon and the broader short-peptide cytomedine family.
Commercial sponsor of SS-31 (elamipretide) clinical development across MMPOWER, ReCLAIM and other programmes.
Pinchas Cohen's group at USC — major contributors to mitochondrially-derived peptide biology (MOTS-c, SHLPs).
Regulatory & reference
UK medicines regulator. Authoritative reference for UK licensing status.
Primary UK legislation governing supply, advertising and promotion of medicines and unlicensed medicinal products.
UK data-protection regulator. Authoritative reference for UK GDPR and data-protection enquiries.